It has been quite a year for Namita Thapar. “All the hard work we put in for Emcure’s IPO (in July) was super successful.

Emcure Pharma on Monday announced the launch of a public awareness campaign on stroke prevention with cricketer MS Dhoni. The ...

Shares of Emcure Pharmaceuticals soared close to 6 percent higher, coming at a kissing distance to its record high of Rs ...

Revenue for Emcure Pharma Q2 rose by over 20%, totaling ₹2,002 Crore, driven by strong performance across segments.

R.I. Attorney General Peter Neronha joined a national coalition of attorneys last week announcing a $49.1 million settlement ...

Revenue grew by 20.4% YoY to ₹2,002 crore, up from ₹1,663 crore in Q2 last fiscal. The company’s EBITDA rose 15.7% to ₹380.8 ...

Shares of Emcure Pharma jumped 6 per cent at Rs 1523.80 a piece on the BSE after the company reported a strong second quarter earnings for the financial year 2024-25 (Q2FY25) ...

Emcure Pharmaceuticals reports strong revenue growth driven by international and domestic businesses, with impressive EBITDA ...

Our Bureau, New Delhi Friday, November 8, 2024, 10:30 Hrs [IST] Pune-based Emcure Pharmaceuticals Ltd has posted growth of 38.2 per ...

Generic drugmakers Apotex and Heritage Pharmaceuticals have agreed to pay nearly $50 million to settle claims by Connecticut ...

It has been quite a year for Namita Thapar. “All the hard work we put in for Emcure’s IPO (in July) was super successful.

Emcure Pharmaceuticals Ltd. announces the launch of a public awareness campaign on stroke prevention with cricket legend, MS Dhoni. Under this initiative, Emcure and Dhoni, through a video urge ...